leisure time -WSS

leisure time

author：leisure time 2025-09-27 09:55:11 - browse：65

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Syphilis numbers in the United States reach record heights

WSS

Boston competes with Raleigh

Merck, Johnson & Johnson CEOs will testify on high drug prices

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Sanofi CEO defends move to abandon profit guidance, boost research

Study: New antibiotic targets gonorrhea as well as last existing drug

White House pharmacy plagued with problems, investigation finds

focus

leisure time

entertainment

Cancer drug shortages should be causing more outrage

The Affordable Care Act has saved billions in health care costs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The new shift in health care is toward less care

United colonoscopy coverage change 'may cost lives,' doctors say

New clues to why women have higher risk of autoimmune disorders

The cancer drug shortage isn’t new — and neither are the solutions

Philips to halt sales of sleep apnea machines in U.S.

Medicare proposal to cover medical devices draws a mixed reaction

Medicare Advantage insurers face 0.2% cut to 2025 payments

focus

Pancreatic cancer early detection could be helped by AI

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

White House calls on federal agencies to crack down on AI abuses

Venture capital firm's plans to take over Akron hospital face hurdles

Wegovy leads to weight loss. Can it treat depression, too?

Vertex non

hotspot

leisure time

focus

focus